This brand name is authorized in Australia, Brazil, Canada, Cyprus, France, Germany, Hong Kong SAR China, Ireland, Israel, Malta, Mexico, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.
The drug CLOPIXOL contains one active pharmaceutical ingredient (API):
1
|
UNII
47ISU063SG - ZUCLOPENTHIXOL
|
|
Zuclopenthixol is a potent neuroleptic of the thioxanthene series with a piperazine side-chain. The antipsychotic effect of neuroleptics is related to their dopamine receptor blocking effect. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| CLOPIXOL Solution for injection | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| CLOPIXOL ACUPHASE Solution for injection | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| CLOPIXOL Film-coated tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| N05AF05 | Zuclopenthixol | N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AF Thioxanthene derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 8097E |
| BR | Câmara de Regulação do Mercado de Medicamentos | 524200201114412, 524200202110410, 524200203151412, 524200204156418 |
| CA | Health Products and Food Branch | 02230402, 02230403, 02230405, 02230406 |
| DE | Bundesinstitut für Arzneimittel und Medizinprodukte | 01125028, 01177930, 02522056, 02752543, 02752566, 03569634, 06585384, 06729469, 09102802, 09321792, 10930740, 13713552, 14136051, 14236605, 15266318, 17562908 |
| ES | Centro de información online de medicamentos de la AEMPS | 60871, 60872, 60873, 60874, 60875 |
| FR | Base de données publique des médicaments | 60209937, 61323662, 62788550, 63744998, 68072846, 69974746 |
| GB | Medicines & Healthcare Products Regulatory Agency | 147150, 147160, 198691, 24633, 24634, 24635, 27619, 27629, 377428, 399365, 41302 |
| HK | Department of Health Drug Office | 19861, 22761 |
| IE | Health Products Regulatory Authority | 17841, 17914, 18139 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 2426, 623, 624, 626, 627, 628, 629, 630, 6787, 6788, 6789, 6790 |
| MT | Medicines Authority | AA565/28903, MA1323/00101 |
| MX | Comisión Federal para la Protección contra Riesgos Sanitarios | 414M96, 415M96, 417M96 |
| NZ | Medicines and Medical Devices Safety Authority | 5434, 5435, 5436 |
| PL | Rejestru Produktów Leczniczych | 100015033, 100015040, 100015056, 100248091 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W10638002, W12431001, W12437002, W12437003, W12439002, W12439003, W13182005 |
| SG | Health Sciences Authority | 01365P |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699795090505, 8699795091335, 8699795091342, 8699795590012, 8699795750201, 8699795750225 |
| ZA | Health Products Regulatory Authority | R/2.6.5/52, T/2.6.5/180, T/2.6.5/181, W/2.6.5/27 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.